Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Nectero Medical
company
About
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.
- 11 - 50
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $19.50M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Medical Device
- Founded date
- Jan 1, 2017
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$19.50M
Nectero Medical has raised a total of
$19.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 10, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 10, 2021 | Series C | $19.50M | 1 |
Boston Scientific
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Nectero Medical is funded by 1 investors.
Boston Scientific
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Boston Scientific
|
Yes | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
